SCHEMBL20111482

SCHEMBL20111482

CCOc1ccc2c(c1F)-c1c-2cc(-c2ccc(C3CCCCO3)cc2)c(F)c1F

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKAG1 P54619 11/20 0.39
PRKAA1 Q13131 11/20 0.39
PRKAB1 Q9Y478 11/20 0.39
PRKAA2 P54646 10/20 0.39
PRKAB2 O43741 8/20 0.39
PRKAG3 Q9UGI9 8/20 0.39
PRKAG2 Q9UGJ0 8/20 0.39
KCNH2 Q12809 2/20 0.35
HRH3 Q9Y5N1 2/20 0.35
KDM1A O60341 2/20 0.33
FGFR2 P21802 1/20 0.32
KDM4E B2RXH2 3/20 0.32
ALDH1A1 P00352 3/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
MEN1 O00255 1/20 0.32
POLB P06746 1/20 0.32
MAPT P10636 1/20 0.32
RECQL P46063 1/20 0.32
BLM P54132 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20111327 0.84 ALDH1A1 (0.36) KDM1AKDM4EALDH1A1L3MBTL1MEN1
SCHEMBL9899628 0.82 KDM1A (0.38) PRKAG1PRKAA1PRKAB1PRKAA2PRKAB2
SCHEMBL20102544 0.81 FASN (0.32)
SCHEMBL20111265 0.75 CAMKK1 (0.36) FGFR2ALDH1A1MAPTLMNA
SCHEMBL20111542 0.75 ADORA3 (0.39) FGFR2KDM4EALDH1A1L3MBTL1MAPT
SCHEMBL16769035 0.72 CYP3A4 (0.41) KDM1AFGFR2KDM4EALDH1A1
SCHEMBL20102450 0.72 PTGDR2 (0.37) KDM1AFGFR2ALDH1A1MAPTLMNA
SCHEMBL20102467 0.72 PTGDR2 (0.37) KDM1AALDH1A1MAPTLMNA
SCHEMBL20111442 0.72 ALDH1A1 (0.30) KDM1AALDH1A1MAPTLMNA
SCHEMBL15681366 0.71 CYP3A4 (0.43) KDM1AKDM4EALDH1A1MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10323187-B2 Liquid crystal compound having biphenylene, liquid crystal composition and liquid crystal display device JNC CORPORATION (JP) 2019-06-18 US disclosed
US-20180119009-A1 LIQUID CRYSTAL COMPOUND HAVING BIPHENYLENE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2018-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180119009-A1 LIQUID CRYSTAL COMPOUND HAVING BIPHENYLENE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE YBX1, PIEZO1, C1S PRKAG1 4189/4885PRKAA1 3088/4885PRKAB1 3543/4885
US-10323187-B2 Liquid crystal compound having biphenylene, liquid crystal composition and liquid crystal display device YBX1, PIEZO1, C1S PRKAG1 4189/4885PRKAA1 3088/4885PRKAB1 3543/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.